Towa Pharmaceutical Co's market cap is currently $140.51B. The company's EPS TTM is ¥391.663; its P/E ratio is 7.29; and it has a dividend yield of 2.10%. Towa Pharmaceutical Co is scheduled to report earnings on February 13, 2025, and the estimated EPS forecast is ¥113.89. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Income Statement
Total Revenue	¥ 227.93B	¥ 208.86B	¥ 165.62B	¥ 154.90B	¥ 110.38B
Gross Profit	¥ 81.38B	¥ 72.71B	¥ 70.19B	¥ 65.45B	¥ 50.65B
Operating Income	¥ 17.65B	¥ 5.51B	¥ 19.20B	¥ 19.92B	¥ 16.14B
EBITDA	¥ 35.54B	¥ 24.92B	¥ 29.49B	¥ 30.35B	¥ 24.46B
Net Income	¥ 16.17B	¥ 2.20B	¥ 15.91B	¥ 13.96B	¥ 14.50B
Balance Sheet
Cash & Short-Term Investments	¥ 29.65B	¥ 24.26B	¥ 32.83B	¥ 22.91B	¥ 18.71B
Total Assets	¥ 430.65B	¥ 371.35B	¥ 329.94B	¥ 245.67B	¥ 228.14B
Total Debt	¥ 202.36B	¥ 173.06B	¥ 144.13B	¥ 84.77B	¥ 82.39B
Net Debt	¥ 172.71B	¥ 148.81B	¥ 111.30B	¥ 61.85B	¥ 63.68B
Total Liabilities	¥ 274.76B	¥ 234.45B	¥ 197.77B	¥ 129.07B	¥ 123.49B
Stockholders' Equity	¥ 155.89B	¥ 136.89B	¥ 132.17B	¥ 116.60B	¥ 104.65B
Cash Flow
Free Cash Flow	¥ -31.11B	¥ -27.93B	¥ 8.55B	¥ 2.13B	¥ 14.49B
Operating Cash Flow	¥ 8.21B	¥ 2.54B	¥ 22.13B	¥ 12.01B	¥ 19.16B
Investing Cash Flow	¥ -40.39B	¥ -30.28B	¥ -59.73B	¥ -9.10B	¥ -39.54B
Financing Cash Flow	¥ 35.41B	¥ 17.48B	¥ 46.54B	¥ 184.00M	¥ 11.75B

Currency in JPY

Towa Pharmaceutical Co Earnings and Revenue History

Income Statement >

Towa Pharmaceutical Co Debt to Assets

Balance Sheet >

Towa Pharmaceutical Co Cash Flow

Cash Flow >

Towa Pharmaceutical Co Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing